Evening primrose is used for premenstrual syndrome (PMS), symptoms of menopause, arthritis, swelling, and other conditions, but there is no good scientific evidence to support its use.
In foods, the oil from evening primrose is used as a source of essential fatty acids.
In manufacturing, the oil from evening primrose is used in soaps and cosmetics.
How does it work ?
Uses & Effectiveness ?
Possibly Effective for
- Nerve damage caused by diabetes. Research shows that taking evening primrose oil daily for 6-12 months improves symptoms of nerve damage caused by diabetes.
- Osteoporosis. Taking evening primrose oil with fish oil and calcium seems to decrease bone loss and increase bone density in elderly people with osteoporosis.
Possibly Ineffective for
- Asthma. Several small studies show that taking 15-20 mL or 4-6 grams of evening primrose daily for up to 16 weeks doesn't improve asthma symptoms.
- Breast pain (mastalgia). High quality research shows that evening primrose is no more effective than a placebo (sugar pill) for reducing breast pain.
Insufficient Evidence for
- Eczema (atopic dermatitis). Research evaluating evening primrose for eczema shows conflicting results. Some research shows that taking evening primrose, up to 6 grams per day by mouth for 3-5 months, reduces the severity and symptoms of eczema in adults and children. However, other studies show that taking evening primrose, 6-8 grams per day in adults or 2-4 grams per day in children for 12-16 weeks, has no benefit. Other early research shows that applying cream containing evening primrose for 2 weeks may improve symptoms of eczema.
- Attention deficit-hyperactivity disorder (ADHD). Early research shows that taking evening primrose, up to 4 grams daily for 4-6 weeks, doesn't seem to improve ADHD symptoms in children.
- Disorders affecting bile flow in the liver. Early research shows that taking 2 grams of evening primrose twice daily for 12 weeks improves itchy skin in some people with disorders affecting bile flow in the liver. Improvement seems to take place within 1-2 weeks of starting treatment.
- Chronic fatigue syndrome (CFS). One early study shows that taking a specific combination of evening primrose and fish oil might reduce CFS-like symptoms that occurred after a viral infection. However, in another study in people with a confirmed diagnosis of CFS, the same product was no better than a placebo (sugar pill).
- Nerve pain in people with diabetes (diabetic neuropathy). Evidence on the effectiveness of evening primrose for treating nerve damage in people with diabetes is conflicting. One study shows that taking up to 6 grams of evening primrose daily for up to 12 months improves how well the nerves work in people with nerve damage caused by diabetes. Other research shows that taking a similar amount of evening primrose does not improve nerve function in people with this condition.
- Dry eye. Early research shows that taking a specific evening primrose product 3 grams daily for 6 months improves dry eye symptoms in people wearing soft contact lenses.
- Swelling (inflammation) of the liver caused by the hepatitis B virus (hepatitis B). Early research shows that taking 4 grams per day of evening primrose for 12 months does not improve liver damage in people with hepatitis B.
- High levels of cholesterol or other fats (lipids) in the blood (hyperlipidemia). Some research shows that taking evening primrose oil can decreases total cholesterol and blood fats called triglycerides while increasing good (HDL) cholesterol. But not all research agrees.
- An inherited skin disorder that causes dry, scaly skin (ichthyosis). Early research shows that taking evening primrose, 3 grams per day in adults or 2 grams per day in children, does not improve symptoms of ichthyosis.
- Infant development. Some early research shows that adding evening primrose and fish oil to regular infant formula might provide levels of some types of fats that are closer to those in breast milk. In one study, infants fed this formula had better eyesight than infants fed regular formula, but not better than those who were breastfed. It's not clear if this benefit results from evening primrose or fish oil.
- Liver cancer. Early research shows that taking 18 grams of evening primrose per day does not affect liver size or survival in people with liver cancer.
- Symptoms of menopause. In most studies, taking evening primrose does not reduce hot flashes or night sweats any more than a placebo (sugar pill). But taking evening primrose oil might help to improve mood.
- Multiple sclerosis (MS). Some early research shows that taking evening primrose for 6 months improves disability scores in some people with MS. But other research shows that using a specific evening primrose product for 2 years may increase the likelihood of symptom worsening compared with a placebo (sugar pill).
- Obesity. Early research shows that taking 4.8 grams of evening primrose per day for 12 weeks does not add to the weight loss achieved with a reduced calorie diet.
- Childbirth. Research evaluating evening primrose for improving childbirth shows conflicting results. One study shows that taking evening primrose for one week before delivery increases the likelihood that vaginal delivery will be successful. However, another study did not show this effect. Other early research shows that taking evening primrose from week 37 of pregnancy until delivery doesn't improve childbirth. In fact, it might prolong labor and increase the need for contraction-inducing medicine (oxytocin).
- A pregnancy complication marked by high blood pressure and protein in the urine (pre-eclampsia). Early research shows that taking evening primrose oil doesn't seem to reduce blood pressure in people with pre-eclampsia.
- Premenstrual syndrome (PMS). Research evaluating evening primrose for PMS shows conflicting results. Some research shows that taking 4 grams daily for 3 months, or 3 grams daily from day 15 until the end of the menstrual cycle for 4 cycles, improves self-reported symptoms. However, other studies using up to 6 grams daily for up to 4 menstrual cycles found no benefit.
- Painful response to cold especially in the fingers and toes (Raynaud syndrome). People with Raynaud syndrome experience reduced blood flow in response to cold or stress. This can cause symptoms such as sores on the fingers and toes. Early research shows that taking 6 grams of evening primrose oil per day for 10 weeks may reduce finger and toe sores in people with this condition. But taking evening primrose oil doesn't seem to improve finger temperature or spasm of the blood vessels caused by cold.
- Rheumatoid arthritis (RA). One early study shows that taking 6 grams per day of evening primrose for 12 months improves self-reported symptoms of RA. However, other research has found evening primrose to be no better than a placebo (sugar pill).
- Schizophrenia. Research evaluating evening primrose for schizophrenia shows conflicting results. One early study shows that taking 6 grams daily for16 weeks improves scores on a psychological rating scale. However, other research shows that taking 4 grams per day of evening primrose for 2-4 months does not benefit people with long-term, severe schizophrenia.
- An autoimmune disorder in which the glands that produce tears and saliva are damaged (Sjogren syndrome). Early research shows that taking evening primrose for 8-10 weeks does not improve dry eye and mouth symptoms in people with Sjogren syndrome.
- A movement disorder often caused by antipsychotic drugs (tardive dyskinesia). Early research shows that taking 6 grams per day of evening primrose for 6-16 weeks does not improve psychiatric drug-induced tardive dyskinesia in schizophrenics.
- Water warts. Early research in children shows that applying evening primrose oil to water warts on the skin for 3 months might cause the lesions to disappear faster than doing nothing at all.
- A motor skill disorder marked by clumsiness (developmental coordination disorder or DCD).
- A learning disorder marked by difficulty reading (dyslexia).
- A painful uterine disorder (endometriosis).
- Leg pain during exercise due to poor blood flow (intermittent claudication).
- A long-term disorder of the large intestines that causes stomach pain (irritable bowel syndrome or IBS).
- Weak and brittle bones (osteoporosis).
- Low bone mass (osteopenia).
- A hormonal disorder that causes enlarged ovaries with cysts (polycystic ovary syndrome or PCOS).
- Scaly, itchy skin (psoriasis).
- Joint swelling (inflammation) in people with psoriasis.
- A type of inflammatory bowel disease (ulcerative colitis)..
- Alzheimer disease.
- Heart disease.
- Stomach ulcers.
- Other conditions.
When applied to the skin: There isn't enough reliable information to know if evening primrose is safe or what the side effects might be.
Special Precautions and Warnings
It is POSSIBLY SAFE to take evening primrose oil during breast-feeding, but it's best to check with your healthcare provider first.
Children: Evening primrose is LIKELY SAFE for most people when taken by mouth in doses up to 6 grams daily. It is also LIKELY SAFE when applied to the skin.
Bleeding disorders: There is a concern that evening primrose might increase the chance of bruising and bleeding. Don't use it if you have a bleeding disorder.
Epilepsy or another seizure disorder: There is a concern that taking evening primrose might make seizures more likely in some people.
Surgery: Evening primrose might increase the chance of bleeding during or after surgery. Stop using it at least 2 weeks before a scheduled surgery.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with EVENING PRIMROSE OIL
Evening primrose oil might slow blood clotting. Taking evening primrose oil along with medications that also slow clotting might increase the chances of bruising and bleeding.
Evening primrose oil contains GLA (gamma-linolenic acid). GLA is the part of evening primrose oil that might slow blood clotting.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.
Do not take this combination
Medications used during surgery (Anesthesia) interacts with EVENING PRIMROSE OIL
Evening primrose oil might interact with medications used during surgery. One person who was taking evening primrose oil and other medications had a seizure during surgery. But there isn't enough information to know if evening primrose oil or the other medications caused the seizure. Be sure to tell your doctor what natural products you are taking before having surgery. To be on the safe side, you should stop taking evening primrose oil at least 2 weeks before surgery.
Phenothiazines interacts with EVENING PRIMROSE OIL
Taking evening primrose oil with phenothiazines might increase the risk of having a seizure in some people.
Some phenothiazines include chlorpromazine (Thorazine), fluphenazine (Prolixin), trifluoperazine (Stelazine), thioridazine (Mellaril), and others.
Be cautious with this combination
- For breast pain: 3-4 grams daily.
Anonymous. Evening primrose hypertension hope. Central 1989;35
Anstey, A. Quigley M. Wilkinson J. D. Topical evening primrose oil as treatment for atopic eczema. J dermatol treat. 1990;1(4):199-201.
Aragona, P., Bucolo, C., Spinella, R., Giuffrida, S., and Ferreri, G. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren's syndrome patients. Invest Ophthalmol.Vis.Sci 2005;46(12):4474-4479. View abstract.
Arisaka, M., Arisaka, O., and Yamashiro, Y. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. Prostaglandins Leukot.Essent.Fatty Acids 1991;43(3):197-201. View abstract.
Bamford, J. T., Gibson, R. W., and Renier, C. M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma- linolenic acids). J Am.Acad.Dermatol. 1985;13(6):959-965. View abstract.
Barabino, S., Rolando, M., Camicione, P., Ravera, G., Zanardi, S., Giuffrida, S., and Calabria, G. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22(2):97-101. View abstract.
Barber A. Evening primrose oil: a panacea? Pharmaceutical J 1988;723-725.
Bates D, Fawcett PRW, Shaw DA, and et all. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J 1978;ii:1390-1391.
Bayles, B. and Usatine, R. Evening primrose oil. Am Fam.Physician 12-15-2009;80(12):1405-1408. View abstract.
Berth-Jones, J., Thompson, J., and Graham-Brown, R. A. Evening primrose oil and atopic eczema. Lancet 2-25-1995;345(8948):520. View abstract.
Biagi, P. L., Bordoni, A., Masi, M., Ricci, G., Fanelli, C., Patrizi, A., and Ceccolini, E. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp Clin Res 1988;14(4):285-290. View abstract.
Boehm, K. Pittler M. H. Wilson N. van Gool C. Humphreys R. Ernst E. Oral evening primrose oil and borage oil for atopic eczema. Cochrane Database Sys Rev 2009;(1):CD004416.
Callender K, McGregor M, and Kirk P. A double-blind trial of evening primrose oil in the premenstrual syndrome: nervous symptom subgroup. Hum Psychopharmacol 1988;3:57-61.
Cameron, M., Gagnier, J. J., and Chrubasik, S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst.Rev. 2011;(2):CD002948. View abstract.
Cameron, M., Gagnier, J. J., Little, C. V., Parsons, T. J., Blumle, A., and Chrubasik, S. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 2: Rheumatoid arthritis. Phytother.Res 2009;23(12):1647-1662. View abstract.
Centre for Reivews and Dissemination.
Centre for Reviews and Dissemination. Oral essential fatty acid supplementation in atopic dermatitis: a meta-analysis of placebo-controlled trials (Structured abstract). 2012;3
Chilton, S. A. Cognitive behaviour therapy for the chronic fatigue syndrome. Evening primrose oil and magnesium have been shown to be effective. BMJ 4-27-1996;312(7038):1096. View abstract.
Conquer, J. A., Roelfsema, H., Zecevic, J., Graham, T. E., and Holub, B. J. Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women. Lipids 2002;37(10):947-951. View abstract.
Coskery G, Cowley N Allen R. The effect of dietary supplementation with evening primrose oil on skin surface texture in atopic dermatitis. J Investigative Dermatitis 1988;91(4):413.
el Ela, S. H., Prasse, K. W., Carroll, R., and Bunce, O. R. Effects of dietary primrose oil on mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene. Lipids 1987;22(12):1041-1044. View abstract.
Endres, S., Lorenz, R., and Loeschke, K. Lipid treatment of inflammatory bowel disease. Curr Opin.Clin Nutr Metab Care 1999;2(2):117-120. View abstract.
Engler MM. The hypotensive effect of dietary gamma-linolenic acid and associated alterations in tissue fatty acid composition and the Renin-Angiotensin system. Abstracts from the International Symposium on Gamma Linolenic Acid, American Oil Chemists Society, Health and Nutrition Division Annual Conference, San Diego, CA, 2000.
Engler, M. M. Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins Leukot.Essent.Fatty Acids 1993;49(4):809-814. View abstract.
Engler, M. M., Schambelan, M., Engler, M. B., Ball, D. L., and Goodfriend, T. L. Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc.Soc.Exp.Biol.Med. 1998;218(3):234-237. View abstract.
Ferrando, J. [Clinical trial of a topical preparation containing urea, sunflower oil, evening primrose oil, wheat germ oil and sodium pyruvate, in several hyperkeratotic skin conditions]. Med Cutan.Ibero.Lat.Am 1986;14(2):133-137. View abstract.
Ferreira MJ, Fiadeiro T Silva M Soares AP. Topical gamma-linolenic acid therapy in atopic dermatitis: a clinical and biometric evaluation. Allergo J 1998;7(4):213-216.
Field, E. J. and Joyce, G. Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur.Neurol. 1978;17(2):67-76. View abstract.
Garcia C, Carter J, and Chou A. Gamma linolenic acid causes weight loss and lower blood pressure in overweight patients with family history of obesity. Swed J Biol Med 1986;4:8-11.
Gateley, C. A. and Mansel, R. E. Management of cyclical breast pain. Br.J Hosp.Med 1990;43(5):330-332. View abstract.
Gateley, C. A. and Mansel, R. E. Management of the painful and nodular breast. Br Med Bull. 1991;47(2):284-294. View abstract.
Gateley, C. A., Maddox, P. R., Mansel, R. E., and Hughes, L. E. Mastalgia refractory to drug treatment. Br J Surg. 1990;77(10):1110-1112. View abstract.
Gateley, C. A., Maddox, P. R., Pritchard, G. A., Sheridan, W., Harrison, B. J., Pye, J. K., Webster, D. J., Hughes, L. E., and Mansel, R. E. Plasma fatty acid profiles in benign breast disorders. Br J Surg. 1992;79(5):407-409. View abstract.
Gateley, C. A., Miers, M., Mansel, R. E., and Hughes, L. E. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. J R.Soc Med 1992;85(1):12-15. View abstract.
Gimenes, O. M., da Silva, M. J., and Benko, M. A. [Flower essences: vibrational intervention of diagnostic and therapeutic possibilities]. Rev.Esc Enferm.USP. 2004;38(4):386-395. View abstract.
Goodwin, P. J., Neelam, M., and Boyd, N. F. Cyclical mastopathy: a critical review of therapy. Br.J Surg. 1988;75(9):837-844. View abstract.
Goyal, A. and Mansel, R. E. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 2005;11(1):41-47. View abstract.
Greaves, M. W. and Corbett, M. F. Treatment of atopic eczema with evening primrose oil. Br.J Dermatol. 1988;118(3):449-451. View abstract.
Gruenwald, J., Graubaum, H. J., and Busch, R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial. Arzneimittelforschung 2005;55(11):669-676. View abstract.
Gruenwald, J., Graubaum, H. J., and Busch, R. Evaluation of the non-inferiority of a fixed combination of thyme fluid- and primrose root extract in comparison to a fixed combination of thyme fluid extract and primrose root tincture in patients with acute bronchitis. A single-blind, randomized, bi-centric clinical trial. Arzneimittelforschung 2006;56(8):574-581. View abstract.
Guenther, L. and Wexler, D. Efamol in the treatment of atopic dermatitis. J Am Acad.Dermatol. 1987;17(5 Pt 1):860. View abstract.
Halat, K. M. and Dennehy, C. E. Botanicals and dietary supplements in diabetic peripheral neuropathy. J Am Board Fam.Pract. 2003;16(1):47-57. View abstract.
Horrobin, D. F. and Morse, P. F. Evening primrose oil and atopic eczema. Lancet 1-28-1995;345(8944):260-261. View abstract.
Horrobin, D. F. and Stewart, C. Evening primrose oil and atopic eczema. Lancet 7-7-1990;336(8706):50. View abstract.
Horrobin, D. F. and Stewart, C. Evening primrose oil in atopic eczema. Lancet 4-7-1990;335(8693):864-865. View abstract.
Horrobin, D. F. Essential fatty acid and prostaglandin metabolism in Sjogren's syndrome, systemic sclerosis and rheumatoid arthritis. Scand.J Rheumatol.Suppl 1986;61:242-245. View abstract.
Horrobin, D. F. Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil. Med Hypotheses 1979;5(3):365-378. View abstract.
Horrobin, D. F. The importance of gamma-linolenic acid and prostaglandin E1 in human nutrition and medicine. Journal of Holistic Medicine. 1981;3(2):118-139.
Hounsom, L., Horrobin, D. F., Tritschler, H., Corder, R., and Tomlinson, D. R. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 1998;41(7):839-843. View abstract.
Humphreys F, Symons J, Brown H, and et al. The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur.J.Dermatol. 1994;4(598):603.
Jamal, G. A., Carmichael, H., and Weir, A. I. Gamma-linolenic acid in diabetic neuropathy. Lancet 5-10-1986;1(8489):1098. View abstract.
Jantti, J., Nikkari, T., Solakivi, T., Vapaatalo, H., and Isomaki, H. Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids. Ann.Rheum.Dis 1989;48(2):124-127. View abstract.
Jaszewska, E., Kosmider, A., Kiss, A. K., and Naruszewicz, M. Oenothera paradoxa defatted seeds extract containing pentagalloylglucose and procyanidins potentiates the cytotoxicity of vincristine. J Physiol Pharmacol 2010;61(5):637-643. View abstract.
Joe, L. A. and Hart, L. L. Evening primrose oil in rheumatoid arthritis. Ann.Pharmacother. 1993;27(12):1475-1477. View abstract.
Johnson, M., Ostlund, S., Fransson, G., Kadesjo, B., and Gillberg, C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J.Atten.Disord. 2009;12(5):394-401. View abstract.
Jones, L. Essential Fatty Acids and Dry Eye: What Do We Know? Contact Lens Spectrum 2009;24(7):14-15.
Kemmerich, B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung 2007;57(9):607-615. View abstract.
Kiehl R, Ionescu G, Manuel P, and et al. Klinische, immun- und lipidmodulatorische effekte einer behandlung mit ungesattigten fettsauren bei atopischer dermatitis. Med.Leiter: J.Muller-Steinwachs 1994;69(1):42-48.
Kiss, A. K., Filipek, A., Czerwinska, M., and Naruszewicz, M. Oenothera paradoxa defatted seeds extract and its bioactive component penta-O-galloyl-beta-D-glucose decreased production of reactive oxygen species and inhibited release of leukotriene B4, interleukin-8, elastase, and myeloperoxidase in human neutrophils. J Agric.Food Chem 9-22-2010;58(18):9960-9966. View abstract.
Kruger, M. C., Coetzer, H., de Winter, R., Gericke, G., and van Papendorp, D. H. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano.) 1998;10(5):385-394.
Langmead, L., Chitnis, M., and Rampton, D. S. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm.Bowel.Dis 2002;8(3):174-179. View abstract.
Liu, H. and Zhou, J. F. [Xianbai buyang Huanwu decoction used for treating hypertension with kidney qi deficiency and blood stasis]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993;13(12):714-7, 707. View abstract.
Liu, L. Z. Wu Q. Liu P. J. Li G. Q. Bensoussan A. Kiat H. Chinese herbal medicines for hypertriglyceridemia. Cochrane Database Sys Rev 2012;(1):CD009560.
Manku, M. S., Horrobin, D. F., Morse, N., Kyte, V., Jenkins, K., Wright, S., and Burton, J. L. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot.Med 1982;9(6):615-628. View abstract.
Mansel RE, Pye JK Hughes LE. Effects of essential fatty acids on cyclical mastalgia and non-cyclical breast disorders. In: Horrobin DF. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Wiley-Liss;1990.
Mansel, R. E., Harrison, B. J., Melhuish, J., Sheridan, W., Pye, J. K., Pritchard, G., Maddox, P. R., Webster, D. J., and Hughes, L. E. A randomized trial of dietary intervention with essential fatty acids in patients with categorized cysts. Ann.N.Y.Acad.Sci. 1990;586:288-294. View abstract.
Martens-Lobenhoffer, J. and Meyer, F. P. Pharmacokinetic data of gamma-linolenic acid in healthy volunteers after the administration of evening primrose oil (Epogam). Int.J Clin Pharmacol Ther. 1998;36(7):363-366. View abstract.
McFayden, I. J., Forrest, A. P., Chetty, U., and Raab, G. Cyclical breast pain--some observations and the difficulties in treatment. Br.J Clin Pract. 1992;46(3):161-164. View abstract.
Meigel, W., Dettke, T., Meigel, E. M., and Lenze, U. [Additional oral therapy of atopic dermatitis with unsaturated fatty acids]. Z.Hautkr. 1987;62 Suppl 1:100-103. View abstract.
Murray, T., Kelsberg, G., Safranek, S., and Crawford, P. Clinical inquiries. Do any folk remedies or herbals help induce labor? J Fam.Pract. 2008;57(8):542-544. View abstract.
Namaka, M., Crook, A., Doupe, A., Kler, K., Vasconcelos, M., Klowak, M., Gong, Y., Wojewnik-Smith, A., and Melanson, M. Examining the evidence: complementary adjunctive therapies for multiple sclerosis. Neurol.Res 2008;30(7):710-719. View abstract.
Newman, V., Rock, C. L., Faerber, S., Flatt, S. W., Wright, F. A., and Pierce, J. P. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet.Assoc. 1998;98(3):285-292. View abstract.
Ockerman PA, Bachrack I, Glans S, and et al. Evening primrose oil as a treatment of premenstrual syndrome. Rec Adv Clin Nutr 1986;2:404-405.
Olsson, R., Tysk, C., Aldenborg, F., and Holm, B. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology 1993;105(1):267-271. View abstract.
Papas, E. Mcoptom D. Dry Eye and Diet: What Research Says About Essential Fatty Acids. Contact Lens Spectrum. 2012;27(3):16-17.
Parveen, S. Sarwar G. Ali M. Channa G. A. Danazol versus oil of evening primrose in the treatment of mastalgia. Pakistan Journal of Surgery. 2007;23(1):10-13.
Pashby N, Mansel R, Hughes L, and et al. A clinical trial of evening primrose in mastalgia. Br J Surg 1981;68:801.
Pellegrina, C. D., Padovani, G., Mainente, F., Zoccatelli, G., Bissoli, G., Mosconi, S., Veneri, G., Peruffo, A., Andrighetto, G., Rizzi, C., and Chignola, R. Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Lett. 8-8-2005;226(1):17-25. View abstract.
Platzbecker, U., Aul, C., Ehninger, G., and Giagounidis, A. Reduction of 5-azacitidine induced skin reactions in MDS patients with evening primrose oil. Ann Hematol. 2010;89(4):427-428. View abstract.
Poisson J, Germain-Bellenger S, Engler M, and et al. Gamma-linolenic acid: A pharmacological nutrient for hypertension? Abstracts from the International Symposium on Gamma Linolenic Acid, American Oil Chemists Society, Health and Nutrition Division Annual Conference, San Diego, CA, 2000.
Preece PE, Hanslip JI Gilbert L. Evening primrose oil (Efamol) for mastalgia. In: Horrobin DF. Clinical Uses of Essential Fatty Acids . Montreal, Quebec: Eden;1982.
Qureshi, S. and Sultan, N. Topical nonsteroidal anti-inflammatory drugs versus oil of evening primrose in the treatment of mastalgia. Surgeon. 2005;3(1):7-10. View abstract.
Ring, J. and Kleinheinz, A. [Evening primrose oil in neurodermatitis?]. Med Monatsschr.Pharm. 1991;14(9):282. View abstract.
Rosolowich, V., Saettler, E., Szuck, B., Lea, R. H., Levesque, P., Weisberg, F., Graham, J., McLeod, L., and Rosolowich, V. Mastalgia. J Obstet.Gynaecol.Can 2006;28(1):49-71. View abstract.
Sharpe, G. R. and Farr, P. M. Evening primrose oil and eczema. Lancet 3-17-1990;335(8690):667-668. View abstract.
Sharpe, G. R. and Farr, P. M. Evening primrose oil and eczema. Lancet 5-26-1990;335(8700):1283. View abstract.
Sholkens BA, Gehring D, Schlotte V, and et al. Evening Primrose oil, a dietary prostaglandin precursor diminishes vascular reactivity to resin and angiotensin II in rats. Prostagland Leukotrienes Med 1982;8:273-285.
Skogh, M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma- linolenic acids). J Am.Acad.Dermatol. 1986;15(1):114-115. View abstract.
Smith, R. L., Pruthi, S., and Fitzpatrick, L. A. Evaluation and management of breast pain. Mayo Clin Proc. 2004;79(3):353-372. View abstract.
Stonemetz, D. A review of the clinical efficacy of evening primrose. Holist.Nurs.Pract. 2008;22(3):171-174. View abstract.
Sture, G. H. and Lloyd, D. H. Canine atopic disease: therapeutic use of an evening primrose oil and fish oil combination. Vet.Rec. 8-12-1995;137(7):169-170. View abstract.
Swapan S, Sabyasachi B Nath GD. Evening primrose oil in treatment of atopic dermatitis: A randomized placebo-controlled trial. Indian Journal of Dermatology, Venereology and Leprology. 2008;(2)
Takahashi, R., Inoue, J., Ito, H., and Hibino, H. Evening primrose oil and fish oil in non-insulin-dependent-diabetes. Prostaglandins Leukot Essent Fatty Acids 1993;49(2):569-571. View abstract.
Tang W, Song YF He ZM. Clinical observation of Blackcurrant oil Soft Capsule and Evening primrose oil Soft Capsule in treating hyperlipidemia. Acta Chinese Medicine and Pharmacology 1993;21(4):37-38.
Taylor, M. Botanicals: medicines and menopause. Clin Obstet.Gynecol. 2001;44(4):853-863. View abstract.
Thuluvath PJ, Triger DR Manku MS Morse-Fisher N. Evening primrose oil in the treatment of severe refractory biliary pruritus. Eur J Gastroenterology and Hepatology 1991;3(1):87-90.
Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report of a therapeutic trial. Br Med J 1955;11:1041-1048.
Ty-Torredes, K. A. The effect of oral evening primrose oil on bishop score and cervical length amongst term gravidas. Am J Obstet Gynecol. 2006;195(6 Suppl 1):S30.
Uccella, R., Contini, A., and Sartorio, M. [Action of evening primrose oil on cardiovascular risk factors in insulin-dependent diabetics]. Clin Ter. 6-15-1989;129(5):381-388. View abstract.
van der Merwe, C. F. Booyens J. A double-blind placebo controlled trial of evening primrose oil (linoleic and gamma-linolenic acid) in primary liver cancer [EASL abstract]. J Hepatol. 1988;7(1):S189.
van Doormaal, J. J., Idema, I. G., Muskiet, F. A., Martini, I. A., and Doorenbos, H. Effects of short-term high dose intake of evening primrose oil on plasma and cellular fatty acid compositions, alpha-tocopherol levels, and erythropoiesis in normal and type 1 (insulin-dependent) diabetic men. Diabetologia 1988;31(8):576-584. View abstract.
Wade, V. A., Mansfield, P. R., and McDonald, P. J. Drug companies' evidence to justify advertising. Lancet 11-25-1989;2(8674):1261-1263. View abstract.
Wetzig, N. R. Mastalgia: a 3 year Australian study. Aust N Z J Surg 1994;64(5):329-331. View abstract.
Whelan, A. M., Jurgens, T. M., and Bowles, S. K. Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother 2006;40(5):836-849. View abstract.
Wolkin, A., Jordan, B., Peselow, E., Rubinstein, M., and Rotrosen, J. Essential fatty acid supplementation in tardive dyskinesia. Am J Psychiatry 1986;143(7):912-914. View abstract.
Woltil, H. A., van Beusekom, C. M., Schaafsma, A., Okken, A., and Muskiet, F. A. Does supplementation of formula with evening primrose and fish oils augment long chain polyunsaturated fatty acid status of low birthweight infants to that of breast-fed counterparts? Prostaglandins Leukot.Essent.Fatty Acids 1999;60(3):199-208. View abstract.
Wright, S. and Burton, J. L. Oral evening-primrose-seed oil improves atopic eczema. Lancet 11-20-1982;2(8308):1120-1122. View abstract.
Yoon, S., Lee, J., and Lee, S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol Appl.Skin Physiol 2002;15(1):20-25. View abstract.
Abraham RD, Riemersma RA, Elton RA, et al. Effects of safflower oil and evening primrose oil in men with a low dihomo-gamma-linolenic level. Atherosclerosis 1990;81:199-208. View abstract.
Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol 1987;15:75-90. View abstract.
Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit hyperactivity disorder: Placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989;25:222-8. View abstract.
Balci FL, Uras C, Feldman S. Clinical factors affecting the therapeutic efficacy of evening primrose oil on mastalgia. Ann Surg Oncol. 2020;27(12):4844-4852. Online ahead of print. View abstract.
Barrett S. Primrose oil and eczema: How research was promoted and suppressed. www.quackwatch.com/01QuackeryRelatedTopics/DSH/epo.html (accessed 09/10/15).
Bassey EJ, Littlewood JJ, Rothwell MC, and Pye DW. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr 2000;83(6):629-635. View abstract.
Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990;82:209-16. View abstract.
Belch J, Hill A. Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 2000;71:352S-6S. View abstract.
Belch JJ, Ansell D, Madhok R, et al. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double blind placebo controlled study. Ann Rheum Dis 1988;47:96-104. View abstract.
Belch JJ, Shaw B, O'Dowd A, Saniabadi A, Leiberman P, Sturrock RD, and Forbes CD. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study. Thromb.Haemost. 8-30-1985;54(2):490-494. View abstract.
Belch JJF, Shaw B, O'Dowd A, et al. Evening primrose oil (Efamol) as a treatment for cold-induced vasospasm (Raynaud's phenomenon). Prog Lipid Res 1986;25:335-40.
Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutrition 2000;19:3-12. View abstract.
Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-60. View abstract.
Biagi PL, Bordoni A, Hrelia S, et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994;20:77-84. View abstract.
Blommers J, de Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol 2002;187:1389-94.. View abstract.
Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res 1988;14:291-7. View abstract.
Brzeski M, Madhok R, and Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side- effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991;30(5):370-372. View abstract.
Campbell ID, Stewart JCM, Royle GT, Taylor I. A randomized controlled trial of EPO for mastalgia. In: Mansel RE (ed). Recent Developments in the Study of Benign Breast Disease. The Proceedings of the 4th International Benign Breast Symposium. Manchester, England, April 1991. pg 89-96.
Cancelo Hidalgo MJ, Castelo-Branco C, Blumel JE, Lanchares Perez J.L, and Alvarez De Los Heros JI. Effect of a compound containing isoflavones, primrose oil and vitamin E in two different doses on climacteric symptoms. J Obstet Gynaecol 2006;26(4):344-347. View abstract.
Cant A, Shay J, Horrobin DF. The effect of maternal supplementation with linoleic and gamma- linolenic acids on the fat composition and content of human milk: a placebo-controlled trial. J Nutr Sci Vitaminol (Tokyo) 1991;37:573-9. View abstract.
Chalmers RJ and Shuster S. Evening primrose seed oil in ichthyosis vulgaris. Lancet 1-29-1983;1(8318):236-237. View abstract.
Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing (abstract). BMJ 1994;308:501-3. View abstract.
Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust N Z J Surg 1999;69:492-4.. View abstract.
Collins A, Cerin A, Coleman G, and Landgren BM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993;81(1):93-98. View abstract.
D'Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19:117-31. View abstract.
Das UN. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essent Fatty Acids 2002;67:1-12. View abstract.
Dove D, Johnson P. Oral evening primrose oil: its effect on length of pregnancy and selected intrapartum outcomes in low-risk nulliparous women (abstract). J Nurse Midwifery 1999;44:320-4. View abstract.
Ebden P, Bevan C, Banks J, Fennerty A, and Walters EH. A study of evening primrose seed oil in atopic asthma. Prostaglandins Leukot Essent Fatty Acids 1989;35(2):69-72. View abstract.
Engler MM, Engler MB, Erickson SK, Paul SM. Dietary gamma-linolenic acid lowers blood pressure and alters aortic reactivity and cholesterol metabolism in hypertension. J Hypertens 1992;10:1197-204. View abstract.
Farzaneh F, Fatehi S, Sohrabi MR, Alizadeh K. The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial. Arch Gynecol Obstet 2013;288(5):1075-9.
Furse RK, Rossetti RG, Seiler CM, Zurier RB. Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes. J Clin Immunol 2002;22:83-91. View abstract.
Gehring W, Bopp R, Rippke F, and Gloor M. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle. Arzneimittelforschung. 1999;49(7):635-642. View abstract.
Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-66. View abstract.
Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 1994;51:311-6. View abstract.
Gupta H, Pawar D, Riva A, et al. A randomized, double-blind, placebo-controlled trial to evaluate efficacy and tolerability of an optimized botanical combination in the management of patients with primary hypercholesterolemia and mixed dyslipidemia. Phytother Res 2012;26:265-272. View abstract.
Hansen TM, Lerche A, Kassis V, et al. Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid. Scand J Rheumatol 1983;12:85-8. View abstract.
Hardy ML. Herbs of special interest to women. J Am Pharm Assoc 200;40:234-42. View abstract.
Haslett C, Douglas JG, Chalmers SR, Weighhill A, and Munro JF. A double-blind evaluation of evening primrose oil as an antiobesity agent. Int.J Obes 1983;7(6):549-553. View abstract.
Head RJ, McLennan PL, Raederstorff D, et al. Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids. Am J Clin Nutr 2000;71:386S-392S. View abstract.
Hederos CA, Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996;75:494-7. View abstract.
Hoare, C., Li Wan, Po A., and Williams, H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4(37):1-191. View abstract.
Holman CP and Bell AF. A trial of evening primrose oil in the treatment of chronic schizophrenia. J Orhtomolecular Psych 1983;12:302-304.
Horner NK, Lampe JW. Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness. J Am Diet Assoc 2000;100:1368-80. View abstract.
Horrobin DF. Evening primrose oil and premenstrual syndrome. Med J Aust 1990;153:630-1. View abstract.
Ishikawa T, Fujiyama Y, Igarashi O, Morino M, Tada N, Kagami A, Sakamoto T, Nagano M, and Nakamura H. Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins. Atherosclerosis 1989;75:95-104. View abstract.
Jaafarnejad F, Abidmoghaddam E, Emami SA, Saki A. Compare the effect of flaxseed, evening primrose oil, and Vitamin E on duration of periodic breast pain. J Educ Health Promot. 2017 Oct 4;6:85. View abstract.
Jalloh MA, Gregory PJ, Hein D, et al. Dietary supplement interactions with antiretrovirals: a systematic review. Int J STD AIDS. 2017 Jan;28(1):4-15. View abstract.
Jamal GA and Carmichael H. The effects of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med 1990;7(4):319-323. View abstract.
Jamal GA. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabet Med 1994;11:145-9. View abstract.
Jamilian M, Karamali M, ,Taghizadeh M, et al. Vitamin D and evening primrose oil administration improve glycemia and lipid profiles in women with gestational diabetes. Lipids. 2016 Mar;51(3):349-56. View abstract.
Jantti J, Seppala E, Vapaatalo H, and Isomaki H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin Rheumatol 1989;8(2):238-244. View abstract.
Jenkins AP, Green AT, and Thompson RP. Essential fatty acid supplementation in chronic hepatitis B. Aliment Pharmacol Ther 1996;10(4):665-668. View abstract.
Kalati M, Kashanian M, Jahdi F, Naseri M, Haghani H, SHeikhansari N. Evening primrose oil and labour, is it effective? A randomized clinical trial. J Obstet Gynaecol. 2018 Feb 9:1-5. View abstract.
Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care 1993;16:8-15. View abstract.
Kenny FS, Pinder SE, Ellis IO, et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 2000;85:643-8. View abstract.
Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 1990;153:189-92. View abstract.
Khorshidi M, Zarezadeh M, Moradi Moghaddam O, et al. Effect of evening primrose oil supplementation on lipid profile: a systematic review and meta-analysis of randomized clinical trials. Phytother Res. 2020;34(10):2628-2638. Online ahead of print. View abstract.
Kilic MO, Sen M, Icen D. The comparison of evening primrose oil, fructus agni casti, and reassurance in the treatment of mastalgia. Int J Surg Med. 2016;2(2):83-88.
Kleijnen J. Evening primrose oil. BMJ 1994;309:824-825. View abstract.
Kokke KH, Morris JA, and Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye 2008;31(3):141-146. View abstract.
Kwon HS, Lee JH, Kim GM, Choi EH, Bae JM. Topical evening primrose oil as a possible therapeutic alternative in children with molluscum contagiosum. Clin Exp Dermatol. 2017 Dec;42(8):923-25. View abstract.
Laivuori H, Hovatta O, Viinikka L, et al. Dietary supplementation with primrose oil or fish oil does not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women. Prostaglandins Leukot Essent Fatty Acids 1993;49:691-4. View abstract.
Liang XC and Guo SS. [Effect of jiang-zhi zhong-yao-pian on total cholesterol, triglyceride, TXB2, 6-keto-PGF1 alpha in hyperlipemic patients]. Zhong Xi Yi Jie He Za Zhi 1991;11:20-2, 4. View abstract.
Lindmark L and Clough P. A 5-month open study with long-chain polyunsaturated fatty acids in dyslexia. J Med Food 2007;10(4):662-6. View abstract.
Lovell CR, Burton JL, and Horrobin DF. Treatment of atopic eczema with evening primrose oil. Lancet 1-31-1981;1(8214):278. View abstract.
Makrides M, Neumann M, Simmer K, Pater J, and Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995;345(8963):1463-1468. View abstract.
Mansel RE, Pye JK Hughes LE. Effects of essential fatty acids on cyclical mastalgia and non-cyclical breast disorders. In: Horrobin DF. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Wiley-Liss;1990.
McKendry RJ. Treatment of Sjogren's syndrome with essential fatty acids, pyridoxine and vitamin C. Prostaglandins Leukot Med 1982;8:403-8. View abstract.
Menendez JA, Colomer R, Lupu R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-Linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells. Int J Cancer 2004;10;109:949-54. View abstract.
Menendez JA, del Mar Barbacid M, Montero S, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 2001;37:402-13. View abstract.
Moodley J and Norman RJ. Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia. Prostaglandins Leukot Essent Fatty Acids 1989;37(3):145-147. View abstract.
Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989;121:75-90. View abstract.
Nasri K, Akrami S, Rahimim M, et al. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind, placebo-controlled trial. Endocr Res. 2018 Feb;43(1):1-10. View abstract.
O'Brien PM, Morrison R, Pipken FB. Effect of dietary supplementation with linoleic and gammalinolenic acids on the pressor response to angiotensin II--possible role in pregnancy induced hypertension? Br J Clin Pharmacol 1985;19:335-42. View abstract.
O'Brien PM, Pipkin FB. The effect of essential fatty acid and specific vitamin supplements on vascular sensitivity in the mid trimester of human pregnancy. Clin Exp Hypertens B 1983;2:247-54. View abstract.
Oliwiecki S and Burton JL. Evening primrose oil and marine oil in the treatment of psoriasis. Clin Exp Dermatol 1994;19(2):127-129.. View abstract.
Osman M, Badawi E. Evening primrose oil reducing serum lithium concentration. Ther Adv Psychopharmacol. 2016 Oct;6(5):343-44. View abstract.
Oxholm P, Manthorpe R, Prause JU, Horrobin D. Patients with primary Sjogren's syndrome treated for two months with evening primrose oil. Scan J Rheumatol 1986;15:103-8. View abstract.
Pashby N, Mansel R, Hughes L, and et al. A clinical trial of evening primrose in mastalgia. Br J Surg 1981;68:801.
Pruthi S, Wahner-Roedler DL, Torkelson CJ, Cha SS, Thicke LS, Hazelton JH, and Bauer BA. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev 2010;15(1):59-67. View abstract.
Puolakka J, Makarainen L, Viinikka L, and Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med 1985;30(3):149-153. View abstract.
Purewal TS, Evans PMS, Havard F, O'Hare JP. Lack of effect of evening primrose oil on autonomic function tests after 12 months of treatment. Diabetologia 1997;40(Suppl 1):A556, abstract 2186.
Puri BK. The safety of evening primrose oil in epilepsy. Prostaglandins Leukotrienes Essential Fatty Acids 2007;77:101-3.
Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet 1985;2:373-7. View abstract.
Rattanatantikul T, Maiprasert M, Sugkraroek P, Bumrungpert A. Efficacy and safety of nutraceutical on menopausal symptoms in post-menopausal women: A randomized, double-blind, placebo-controlled clinical trial. J Diet Suppl. 2020:1-15. View abstract.
Rezapour-Firouzi S, Arefhosseini SR, Mehdi F, et al. Immunomodulatory and therapeutic effects of Hot-natured diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients. Complement Ther Med 2013;21(5):473-80.
Roemheld-Hamm B, Dahl NV. Herbs, menopause, and dialysis. Semin Dial 2002;15:53-9.. View abstract.
Rose DP, Connolly JM, Liu XH. Effects of linoleic acid and gamma-linolenic acid on the growth and metastasis of a human breast cancer cell line in nude mice and on its growth and invasive capacity in vitro. Nutr Cancer 1995;24:33-45. . View abstract.
Saied GM, Kamel RM, and Dessouki N. Low intensity laser therapy is comparable to bromocriptine-evening primrose oil for the treatment of cyclical mastalgia in Egyptian females. Tanzan Health Res Bull 2007;9(3):196-201. View abstract.
Schalin-Karrila M, Mattila L, Jansen CT, Uotila P. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br J Dermatol 1987;117:11-9. View abstract.
Senapati S, Banerjee S, and Gangopadhyay DN. Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial. Indian J Dermatol.Venereol.Leprol. 2008;74(5):447-452. View abstract.
Sharif SN, Darsareh F. Impact of evening primrose oil consumption on psychological symptoms of postmenopausal women: a randomized double-blinded placebo-controlled clinical trial. Menopause. 2020;27(2):194-198. View abstract.
Sharma N, Gupta A, Jha PK, Rajput P. Mastalgia cured! Randomized trial comparing centchroman to evening primrose oil (letter). The Breast Journal 2012;18(5):509-10.
Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991-1995). Drug Saf 1997;17:342-56. View abstract.
Shuster J. Black cohosh root? Chasteberry Tree? Seizures! Hosp Pharm 1996;31:1553-4.
Sinn N, Bryan J. Effect of Supplementation with Polyunsaturated Fatty Acids and Micronutrients on Learning and Behavior Problems Associated with Child ADHD. J Dev Behav Pediatr 2007;28:82-91. View abstract.
Srivastava A, Mansel RE, Arvind N, Prasad K, Dhar A, and Chabra A. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast 2007;16(5):503-512. View abstract.
Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, and Vapaatalo H. Evening primrose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy 1989;62(6):534-537. View abstract.
Stordy BJ. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr 2000;71:323S-6S. View abstract.
Strong A and Hamill E. The effect of combined fish oil and evening primrose oil (Efamol Marine) on the remission phase of psoriasis: a 7-month double-blind randomized placebo-controlled trial. Journal of Dermatological Treatment 1993;4:33-36.
Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 2003;327:1385. View abstract.
Tang W, Song YF He ZM. Clinical observation of Blackcurrant oil Soft Capsule and Evening primrose oil Soft Capsule in treating hyperlipidemia. Acta Chinese Medicine and Pharmacology 1993;21(4):37-38.
The Medicines Control Agency (MCA), Epogam and Efamast (gamolenic acid) - withdrawal of marketing authorizations. https://www.mca.gov.uk/whatsnew/epogam.htm. (Accessed 2 June 2003).
Tong M. [Treatment of hyperlipemia with evening primrose oil capsules]. Zhong Xi Yi Jie He Za Zhi. 1988;8:469-71, 452-3. View abstract.
Ty-Torredes KA. The effect of oral evening primrose oil on bishop score and cervical length amongst term gravidas. Am J Obstet Gynecol. 2006;195(6 Suppl 1):S30.
Vaddadi KS, Courtney P, Gilleard CJ, Manku MS, and Horrobin DF. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Res 1989;27(3):313-323. View abstract.
Vaddadi KS. The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostaglandins Med 1981;6(4):375-379. View abstract.
van der Merwe CF, Booyens J, Joubert HF, van der Merwe CA. The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver cancer. A double- blind placebo controlled trial. Prostaglandins Leukot Essent Fatty Acids 1990;40:199-202. View abstract.
van Gool CJ, Zeegers MP, Thijs C. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials. Br J Dermatol 2004;150:728-40. View abstract.
Veale DJ, Torley HI, Richards IM, O'Dowd A, Fitzsimons C, Belch JJ, and Sturrock RD. A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis. Br J Rheumatol 1994;33(10):954-958. View abstract.
Veselinovic M, Vasiljevic D, Vucic V, et al. Clinical benefits of n-3 PUFA and gamma-Linolenic acid in patients with rheumatoid arthritis. Nutrients. 2017 Mar 25;9(4). View abstract.
Viikari J and Lehtonen A. Effect of primrose oil on serum lipids and blood pressure in hyperlipidemic subjects. Int J Clin Pharmacol Ther Toxicol 1986;2:668-670. View abstract.
Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999;99:112-6. View abstract.
Wedig KE, Whitsett JA. Down the primrose path: petechiae in a neonate exposed to herbal remedy for parturition. J Pediatr 2008;152:140, 140.e1. View abstract.
Whitaker DK, Cilliers J, de Beer C. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results. Dermatology 1996;193:115-20. View abstract.
Williams HC. Evening primrose oil for atopic dermatitis. BMJ 2003;327:1358-9. View abstract.
Wright S. Atopic dermatitis and essential fatty acids: a biochemical basis for atopy? Acta Derm Venereol Suppl (Stockh) 1985;114:143-145. View abstract.
Zou L, Harkey MR, and Henderson GL. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 8-16-2002;71(13):1579-1589. View abstract.
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.